iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionMission Wealth Management, Lp
Latest Disclosed Ownership2,242 shares
Latest Disclosed Value $ 378,481
Mission Wealth Management, Lp reports 0.36% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 15, 2026 - Mission Wealth Management, Lp filed a 13F-HR form disclosing ownership of 2,242 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $378,481 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 2,234 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.36% during the quarter. The current value of the position is $293,814 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,242 8 0.36 378 0.53 0.0078
2026-02-05 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,234 0 0.00 377 16.77 0.0075
2025-11-04 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,234 0 0.00 322 14.18 0.0064
2025-08-05 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,234 -58 -2.53 283 -3.75 0.0060
2025-04-17 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,292 -754 -24.75 293 -27.11 0.0072
2025-02-06 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,046 24 0.79 403 -8.43 0.0094
2024-10-31 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,022 0 0.00 440 6.04 0.0106
2024-08-05 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,022 0 0.00 415 0.00 0.0110
2024-04-30 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,022 0 0.00 415 0.98 0.0109
2024-02-05 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,022 506 20.11 410 33.55 0.0133
2023-10-24 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,516 -230 -8.38 308 -11.78 0.0115
2023-08-04 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,746 120 4.57 349 2.65 0.0132
2023-04-07 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,626 -276 -9.51 339 -11.02 0.0142
2023-02-02 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,902 34 1.19 381 13.73 0.0182
2022-10-12 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,868 -148 -4.91 335 -5.63 0.0177
2022-07-27 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,016 613 25.51 355 13.42 0.0187
2022-04-25 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,403 212 9.68 313 -6.29 0.0145
2022-02-11 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,191 75 3.54 334 -2.34 0.0150
2021-11-05 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,116 -500 -19.11 342 -20.09 0.0174
2021-08-10 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,616 602 29.89 428 41.25 0.0227
2021-05-10 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,014 325 19.24 303 18.36 0.0176
2021-01-19 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,689 120 7.65 256 20.75 0.0160
2020-10-16 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 1,569 70 4.67 212 3.41 0.0159
2020-08-03 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 1,499 1,499 205 0.0177
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.